University of Cincinnati Department of Psychiatry and Behavioral Neuroscience is a clinical research site located in Cincinnati, Ohio, United States 45219.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Attention Deficit/Hyperactivity Disorder, Fibromyalgia, Attention Deficit Hyperactivity Disorder.
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Supernus Pharmaceuticals, Inc..
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience has 4 clinical trials on record, with 1 currently active. Their work covers Attention Deficit/Hyperactivity Disorder, Fibromyalgia, Attention Deficit Hyperactivity Disorder.
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.